Nel ASA's 1.6 Billion NOK War Chest Awaits a Revenue Breakthrough

Nel ASA faces investor pressure as record orders fail to boost revenue. Q1 results on April 22 must show a path to profitability amid analyst skepticism and internal restructuring.

Investors in hydrogen specialist Nel ASA are caught in a holding pattern, balancing a record order backlog against persistent revenue shortfalls. The stock, trading at 0.20 EUR, reflects this tension, having lost over three percent recently to hover precisely at its 200-day moving average. With first-quarter results due on April 22, the market is demanding concrete signs that booming contracts will finally translate into booked sales.

The core challenge is starkly visible in the company's financials. While order intake, particularly in the PEM division, exploded by 364 percent late last year to 686 million Norwegian Kroner (NOK), revenue from customer contracts fell by a fifth. This gap contributes directly to a substantial net loss of 1.27 billion NOK for the full year 2025. The operational cash drain remains a primary concern for analysts, leading to a cautious consensus that currently recommends underweighting the stock.

Wall Street's skepticism has hardened in the run-up to the quarterly report. Morgan Stanley slashed its price target from 3.50 to 2.00 NOK, while Citi set its target at 2.40 NOK. Both banks, alongside Berenberg, maintain a "Hold" rating. Their unified critique centers on Nel's struggle to convert its impressive order book into tangible earnings, compounded by risks associated with its new technology platform.

Internally, the pressure is manifesting in revised executive compensation. During the Annual General Meeting on April 10, shareholders scrapped the old stock option program. It was replaced with a purely performance-based model, awarding approximately 15 million Performance Share Units to management. Executives will now receive actual shares only upon hitting specific operational milestones, a move designed to align leadership incentives more closely with corporate performance. Strategic oversight continues with a representative from Samsung E&A remaining on the board.

Technologically, the company is banking on its next-generation pressurized alkaline electrolyzer platform to be a game-changer. A prototype has successfully passed tests, and the system promises to slash manufacturing costs by up to 60 percent. Market launch is scheduled for the first half of 2026, backed by a 135 million EUR grant from the European Union.

Financially, Nel enters this critical period with a robust buffer. Liquidity reserves stand at approximately 1.6 billion NOK, deemed sufficient to fund the initial scale-up phase. The management has now entered a quiet period ahead of the earnings release, pausing investor communications.

However, legacy issues threaten the balance sheet. The company is reviewing the book values of two idled production lines at its Herøya facility, a process that may force further write-downs. Clarifying the exact extent of these potential impairments is a key piece of information expected from the upcoming report.

The April 22 disclosure is therefore a pivotal moment. It must provide clear evidence that the recent contract surge is beginning to close the revenue gap and offer transparency on the Herøya asset review. Without such proof, the stock may struggle to find a sustainable recovery path. Investors will then look ahead to the next major update in the half-year report on July 15, 2026.